Company Overview and News
(Sept 18): HSBC Holdings Plc is planning to increase its wealth-management staff in Asia, as Chief Executive Officer John Flint bets on growth in the region.
DGLD HSNGF CS 0011 HSB D05 UGLD HSNGY UBS DBSDF HSBC HBCYF DBSDY DSLV C VIIX BHKLY CSSLF VIIZ 2388 HCS 0005 CSGKF CGBBW BNKHF HSEA HSEB ZIV USLV TVIX ULSGF XIV
Sept 17 (Reuters) - Bank of America Corp has appointed Marco Chisari and Rob Brass as co-heads of global semiconductor investment banking in a move aimed to deepen the bank’s focus on the sector, according to a memo published on Monday and confirmed by a spokesman.
DB DGLD CS UGLD MSCC UBS AVGO MS DSLV C VIIX CSSLF VIIZ CSGKF CGBBW MU ZIV USLV BRCM TVIX QCOM ULSGF XIV
UBS Group AG (UBS - Free Report) has selected Germany’s financial hub Frankfurt over London as its new base for post-Brexit operations, per Bloomberg. Additionally, UBS plans to open offices in Madrid, Paris and Milan as part of its multi-location strategy in the European Union.
DB HCS HSB 0005 UBS HSEA HSEB HSBC ULSGF HBCYF
Hong Kong/Singapore: UBS Group AG has picked Frankfurt as its post-Brexit European Union hub and has made preparations for the worst-case scenario of Britain crashing out of the bloc without a trade deal, chief executive officer Sergio Ermotti said.
Big European bank: A Swiss flag flying over a sign of Swiss bank Credit Suisse in Bern. While Credit Suisse is still one of Europe’s largest investment banks, its main focus is managing money for wealthy entrepreneurs around the globe and especially in emerging markets. — AFP
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS ZIV USLV TVIX ULSGF XIV
2018-09-13 zacks - 1
Chicago, IL –September 13, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc (AAPL - Free Report) , Microsoft Corp. (MSFT - Free Report) , Xilinx, Inc. (XLNX - Free Report) , ON Semiconductor Corp.
XLNX VTNR HBIO ON TCP UBS SUMR AAPL ICE MSFT AZPN ULSGF
Political scandals and blistering criticism have been bogging down tech companies for a while now. But, Apple Inc’s (AAPL - Free Report) reversal of a four-day losing streak ahead of its annual product launch boosted the overall sector. We also shouldn’t forget that tech stocks have been the strongest performers so far this year, with both computer and software makers, and chip-related companies making giant strides on tax reforms and fundamentals.
XLNX GS GLSSP UBS AAPL JBK GSC TFG ON GSJ MSFT GJS AZPN ULSGF
New York: Apple Inc. rose the most in five weeks on heavier-than-average volume as investors piled in on the eve of the company’s annual iPhone introduction. The shares rallied 2.5% Tuesday, increasing the gain since the start of the year to 32%. More than 35 million shares changed hands, which is 1.4 times the three-month average. The company is expected to unveil three new iPhone models in Cupertino, California on Wednesday.
JBK GSC TFG GSJ GS GLSSP UBS AAPL GJS ULSGF
Sept 7 (Reuters) - Deutsche Bank AG has appointed veteran investment banker Ajay Shah to the newly created role of head of technology in the Americas, the German bank said in an internal memo on Friday that was seen by Reuters and confirmed by a spokesperson.
OCLR DB KEYS UBS LITE ULSGF HPE
Seven years ago this week, a cryptic post appeared on UBS Group AG trader Kweku Adoboli’s Facebook page: “Need a miracle.” He was on his way to racking up a $2 billion shortfall that would become the biggest unauthorized trading loss in British history.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS LNSTY ZIV USLV TVIX ULSGF XIV
2018-09-03 theedgemarkets - 1
Competition to manage the money of Asia’s burgeoning army of millionaires has pushed pay hikes for wealth managers to the highest in more than a decade. Those willing to jump to a rival are getting increases of 30 percent or more in Hong Kong and Singapore, according to private bankers and recruiters.
DSLV VIIX DGLD CSSLF VIIZ CS O39 CSGKF UGLD UBS ZIV USLV TVIX ULSGF XIV
SINGAPORE (Sept 3): UBS Group AG will introduce a new electronic currency pricing and trading engine in Singapore next year in a bid to boost liquidity in Asia’s largest foreign-exchange center.
UBS ULSGF ERM
2018-09-03 seekingalpha - 9
This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking David Tepper’s Appaloosa Management Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q1 2018.
PCG LRCX SYMC KMT CQP CNC VST XOP KEY NRGEO CFIN WPZ BSX CIWV HCA SYK AABA AMAT WMB SUM BTUUQ VNTR BAC TMUSP LNG TMUS OC NRG ALL BABA ETP CZR GOOGL WMIH TERP WFCNP MGM FB PAH AY TMO WDC NVDA GOOG BAC HUN AGN UBS WFC WMIHP GJT XPO CFG BTU ALLY MU VSTE URI DG ULSGF
10h - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
10h - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
12h - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to UBS / UBS Group AG on message board site Silicon Investor.
as of ET